ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NURO NeuroMetrix Inc

4.55
0.08 (1.79%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
NeuroMetrix Inc NURO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.08 1.79% 4.55 14:00:07
Open Price Low Price High Price Close Price Previous Close
4.45 4.28 4.45 4.30 4.47
more quote information »

Recent News

Date Time Source Heading
19/4/202422:00GLOBENeuroMetrix Announces Steps Taken to Enhance Shareholder..
15/3/202400:00GLOBENeuroMetrix Announces Publication of Study Demonstrating..
14/3/202400:00GLOBENeuroMetrix announces that over 2000 patients with..
07/3/202409:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202409:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202409:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202409:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202408:12EDGAR2Form SC 13D/A - General statement of acquisition of..
02/3/202409:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202408:45EDGAR2Form 8-K/A - Current report: [Amend]
28/2/202408:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
27/2/202409:41EDGAR2Form SC 13D - General statement of acquisition of beneficial..
22/2/202423:15EDGAR2Form 8-K - Current report
22/2/202423:00GLOBENeuroMetrix Reports Q4 and Full Year 2023 Business..
21/2/202406:49EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
16/2/202401:00GLOBENeuroMetrix, Inc. Announces Date for Fourth Quarter and Full..
14/2/202401:00GLOBENeuroMetrix Announces Review of Strategic Options to Promote..
13/12/202301:00GLOBENeuroMetrix Reports Encouraging Results from Pilot Clinical..
06/12/202301:00GLOBENeuroMetrix Announces Peer-Reviewed Publication of Phase 2..
21/11/202301:33EDGAR2Form 8-K - Current report
21/11/202301:00GLOBENeuroMetrix Announces One-for-Eight Reverse Stock Split
27/10/202307:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/10/202322:11EDGAR2Form 8-K - Current report
26/10/202322:00GLOBENeuroMetrix Reports Q3 2023 Business Highlights
24/10/202302:13GLOBENeuroMetrix, Inc. Announces Date for Third Quarter 2023..
21/10/202305:59EDGAR2Form 8-K - Current report
03/10/202300:00GLOBENeuroMetrix and the National Fibromyalgia Association to..
11/9/202321:59EDGAR2Form DEF 14A - Other definitive proxy statements
12/8/202307:11EDGAR2Form 8-K - Current report
05/8/202308:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202308:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202308:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202307:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202306:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/7/202306:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/7/202321:24EDGAR2Form 8-K - Current report
27/7/202321:00GLOBENeuroMetrix Reports Q2 2023 Business Highlights
21/7/202303:00GLOBENeuroMetrix, Inc. Announces Date for Second Quarter 2023..
11/7/202323:00GLOBENeuroMetrix Announces Sales Force Expansion for Quell..
28/6/202323:00GLOBERecent Publications Demonstrate Utility of DPNCheck® for..
07/6/202323:00GLOBEDiabetic Peripheral Neuropathy Screening That Includes..
31/5/202323:00GLOBEQuell® Demonstrates Encouraging Clinical Trial Results in..

Your Recent History

Delayed Upgrade Clock